|
1
|
Cao X, Zhang Y, Zhou Q, Sun S, He M, Wang X, Ma P, Yang X, Lv L, Zhan L. Establishment of a Novel Mouse Hepatocellular Carcinoma Model for Dynamic Monitoring of Tumor Development by Bioluminescence Imaging. Front Oncol 2022; 12:794101. [PMID: 35251971 PMCID: PMC8891637 DOI: 10.3389/fonc.2022.794101] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2021] [Accepted: 01/21/2022] [Indexed: 11/25/2022] Open
Abstract
In this study, a novel mouse model of hepatocellular carcinoma (HCC) was established by simultaneously knocking out Pten and p53 suppressor genes and overexpressing c-Met and △90-β-catenin proto-oncogenes in the livers of mice via hydrodynamic injection (HDI). The mutations were introduced using the CRISPR/Cas9 and Sleeping Beauty transposon systems. In this way, a primary liver cancer model was established within six weeks. In addition, macrophages expressing arginase-1(Arg1) promoter coupled with firefly luciferase were engineered for bioluminescence imaging (BLI) of the tumor microenvironment. This novel, rapidly-generated model of primary hepatocellular carcinoma can be monitored noninvasively, which can facilitate not only applications of the model, but also the development of new drugs and treatment strategies of HCC.
Collapse
Affiliation(s)
- Xiangyi Cao
- Department of Transfusion Medicine, Institute of Health Service and Transfusion Medicine, Beijing, China
- Zhengzhou University, BGI College and Henan Institute of Medical and Pharmaceutical Sciences, Academy of Medical Science, Zhengzhou University, Zhengzhou, China
| | - Yulong Zhang
- Department of Transfusion Medicine, Institute of Health Service and Transfusion Medicine, Beijing, China
| | - Qianqian Zhou
- Department of Transfusion Medicine, Institute of Health Service and Transfusion Medicine, Beijing, China
| | - Sujing Sun
- Department of Transfusion Medicine, Institute of Health Service and Transfusion Medicine, Beijing, China
| | - Minwei He
- Department of Transfusion Medicine, Institute of Health Service and Transfusion Medicine, Beijing, China
| | - Xiaohui Wang
- Department of Transfusion Medicine, Institute of Health Service and Transfusion Medicine, Beijing, China
| | - Ping Ma
- Department of Transfusion Medicine, Institute of Health Service and Transfusion Medicine, Beijing, China
| | - Xiaoang Yang
- Zhengzhou University, BGI College and Henan Institute of Medical and Pharmaceutical Sciences, Academy of Medical Science, Zhengzhou University, Zhengzhou, China
| | - Liping Lv
- Department of Transfusion Medicine, Institute of Health Service and Transfusion Medicine, Beijing, China
- *Correspondence: Linsheng Zhan, ; Liping Lv,
| | - Linsheng Zhan
- Department of Transfusion Medicine, Institute of Health Service and Transfusion Medicine, Beijing, China
- *Correspondence: Linsheng Zhan, ; Liping Lv,
| |
Collapse
|